APO Research
Talk to an analyst

APO RESEARCH · REPORT

Subcutaneous Allergy Immunotherapies

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Subcutaneous Allergy Immunotherapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025185 pages

Choose your research edition.

Industry ResearchSubcutaneous Allergy Immunotherapies Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Subcutaneous Allergy Immunotherapies Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Subcutaneous Allergy Immunotherapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Subcutaneous Allergy Immunotherapies Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Subcutaneous Allergy Immunotherapies Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Subcutaneous Allergy Immunotherapies market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Subcutaneous Allergy Immunotherapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Subcutaneous Allergy Immunotherapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Subcutaneous Allergy Immunotherapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Subcutaneous Allergy Immunotherapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Subcutaneous Allergy Immunotherapies include Merck, WOLW Pharma, Stallergenes Greer, Leti, Holister Stier, HAL, Allergy Therapeutics and ALK-Abello, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Subcutaneous Allergy Immunotherapies market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Subcutaneous Allergy Immunotherapies and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Subcutaneous Allergy Immunotherapies sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Subcutaneous Allergy Immunotherapies market size, projected growth trends, production technologies, key applications, and end-use industries.

Subcutaneous Allergy Immunotherapies Segment by Company

Merck

WOLW Pharma

Stallergenes Greer

Leti

Holister Stier

HAL

Allergy Therapeutics

ALK-Abello

Subcutaneous Allergy Immunotherapies Segment by Type

High Concentration

Low Concentration

Subcutaneous Allergy Immunotherapies Segment by Application

Primary Immunodeficiency

Secondary Immunodeficiency

Others

Subcutaneous Allergy Immunotherapies Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Subcutaneous Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Subcutaneous Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Subcutaneous Allergy Immunotherapies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Subcutaneous Allergy Immunotherapies market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Subcutaneous Allergy Immunotherapies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Subcutaneous Allergy Immunotherapies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Subcutaneous Allergy Immunotherapies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Subcutaneous Allergy Immunotherapies Industry Trends Table 2. Subcutaneous Allergy Immunotherapies Industry Drivers Table 3. Subcutaneous Allergy Immunotherapies Industry Opportunities and Challenges Table 4. Subcutaneous Allergy Immunotherapies Industry Restraints Table 5. Global Subcutaneous Allergy Immunotherapies Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Subcutaneous Allergy Immunotherapies Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Manufacturers Table 9. Global Subcutaneous Allergy Immunotherapies Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Subcutaneous Allergy Immunotherapies Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Subcutaneous Allergy Immunotherapies Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Subcutaneous Allergy Immunotherapies Manufacturers, Product Type & Application Table 13. Global Subcutaneous Allergy Immunotherapies Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Subcutaneous Allergy Immunotherapies by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of High Concentration Table 17. Major Manufacturers of Low Concentration Table 18. Global Subcutaneous Allergy Immunotherapies Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (K Units) Table 20. Global Subcutaneous Allergy Immunotherapies Sales by Type (2027-2032) & (K Units) Table 21. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2021-2026) Table 22. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2027-2032) Table 23. Global Subcutaneous Allergy Immunotherapies Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Subcutaneous Allergy Immunotherapies Revenue by Type (2021-2026) & (K Units) Table 25. Global Subcutaneous Allergy Immunotherapies Revenue by Type (2027-2032) & (K Units) Table 26. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2021-2026) Table 27. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Primary Immunodeficiency Table 29. Major Manufacturers of Secondary Immunodeficiency Table 30. Major Manufacturers of Others Table 31. Global Subcutaneous Allergy Immunotherapies Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (K Units) Table 33. Global Subcutaneous Allergy Immunotherapies Sales by Application (2027-2032) & (K Units) Table 34. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2021-2026) Table 35. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2027-2032) Table 36. Global Subcutaneous Allergy Immunotherapies Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Subcutaneous Allergy Immunotherapies Revenue by Application (2021-2026) & (K Units) Table 38. Global Subcutaneous Allergy Immunotherapies Revenue by Application (2027-2032) & (K Units) Table 39. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2021-2026) Table 40. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2027-2032) Table 41. Global Subcutaneous Allergy Immunotherapies Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Subcutaneous Allergy Immunotherapies Sales by Region (2021-2026) & (K Units) Table 43. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2021-2026) Table 44. Global Subcutaneous Allergy Immunotherapies Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Subcutaneous Allergy Immunotherapies Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Subcutaneous Allergy Immunotherapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026) & (K Units) Table 48. North America Subcutaneous Allergy Immunotherapies Sales by Country (2027-2032) & (K Units) Table 49. Europe Subcutaneous Allergy Immunotherapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026) & (K Units) Table 51. Europe Subcutaneous Allergy Immunotherapies Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Subcutaneous Allergy Immunotherapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2027-2032) & (K Units) Table 58. Global Subcutaneous Allergy Immunotherapies Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Subcutaneous Allergy Immunotherapies Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Subcutaneous Allergy Immunotherapies Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2021-2026) Table 62. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2027-2032) Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Subcutaneous Allergy Immunotherapies Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merck Subcutaneous Allergy Immunotherapies Product Portfolio Table 67. Merck Recent Development Table 68. WOLW Pharma Company Information Table 69. WOLW Pharma Business Overview Table 70. WOLW Pharma Subcutaneous Allergy Immunotherapies Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. WOLW Pharma Subcutaneous Allergy Immunotherapies Product Portfolio Table 72. WOLW Pharma Recent Development Table 73. Stallergenes Greer Company Information Table 74. Stallergenes Greer Business Overview Table 75. Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Portfolio Table 77. Stallergenes Greer Recent Development Table 78. Leti Company Information Table 79. Leti Business Overview Table 80. Leti Subcutaneous Allergy Immunotherapies Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Leti Subcutaneous Allergy Immunotherapies Product Portfolio Table 82. Leti Recent Development Table 83. Holister Stier Company Information Table 84. Holister Stier Business Overview Table 85. Holister Stier Subcutaneous Allergy Immunotherapies Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Holister Stier Subcutaneous Allergy Immunotherapies Product Portfolio Table 87. Holister Stier Recent Development Table 88. HAL Company Information Table 89. HAL Business Overview Table 90. HAL Subcutaneous Allergy Immunotherapies Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. HAL Subcutaneous Allergy Immunotherapies Product Portfolio Table 92. HAL Recent Development Table 93. Allergy Therapeutics Company Information Table 94. Allergy Therapeutics Business Overview Table 95. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Portfolio Table 97. Allergy Therapeutics Recent Development Table 98. ALK-Abello Company Information Table 99. ALK-Abello Business Overview Table 100. ALK-Abello Subcutaneous Allergy Immunotherapies Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. ALK-Abello Subcutaneous Allergy Immunotherapies Product Portfolio Table 102. ALK-Abello Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Subcutaneous Allergy Immunotherapies Distributors List Table 106. Subcutaneous Allergy Immunotherapies Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Subcutaneous Allergy Immunotherapies Product Image Figure 2. Global Subcutaneous Allergy Immunotherapies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Subcutaneous Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 4. Global Subcutaneous Allergy Immunotherapies Sales (2021-2032) & (K Units) Figure 5. Global Subcutaneous Allergy Immunotherapies Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Subcutaneous Allergy Immunotherapies Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. High Concentration Image Figure 9. Low Concentration Image Figure 10. Global Subcutaneous Allergy Immunotherapies Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Subcutaneous Allergy Immunotherapies Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2021-2032) Figure 13. Global Subcutaneous Allergy Immunotherapies Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Subcutaneous Allergy Immunotherapies Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2021-2032) Figure 16. Primary Immunodeficiency Image Figure 17. Secondary Immunodeficiency Image Figure 18. Others Image Figure 19. Global Subcutaneous Allergy Immunotherapies Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Subcutaneous Allergy Immunotherapies Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2021-2032) Figure 22. Global Subcutaneous Allergy Immunotherapies Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Subcutaneous Allergy Immunotherapies Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2021-2032) Figure 25. North America Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2021-2032) Figure 27. U.S. Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2021-2032) Figure 32. Germany Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2021-2032) Figure 39. China Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2021-2032) Figure 47. Brazil Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Subcutaneous Allergy Immunotherapies Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Subcutaneous Allergy Immunotherapies Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Subcutaneous Allergy Immunotherapies Revenue (2021-2032) & (US$ Million) Figure 58. North America Subcutaneous Allergy Immunotherapies Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Subcutaneous Allergy Immunotherapies Revenue (2021-2032) & (US$ Million) Figure 60. Europe Subcutaneous Allergy Immunotherapies Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Subcutaneous Allergy Immunotherapies Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Subcutaneous Allergy Immunotherapies Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Subcutaneous Allergy Immunotherapies Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Subcutaneous Allergy Immunotherapies Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • High Concentration
  • Low Concentration
Applications
  • Primary Immunodeficiency
  • Secondary Immunodeficiency
  • Others
Companies covered
  • Merck
  • WOLW Pharma
  • Stallergenes Greer
  • Leti
  • Holister Stier
  • HAL
  • Allergy Therapeutics
  • ALK-Abello

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Subcutaneous Allergy Immunotherapies Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Subcutaneous Allergy Immunotherapies Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Subcutaneous Allergy Immunotherapies Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Subcutaneous Allergy Immunotherapies Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Subcutaneous Allergy Immunotherapies Market Dynamics
  1. 2.1 Subcutaneous Allergy Immunotherapies Industry Trends
  2. 2.2 Subcutaneous Allergy Immunotherapies Industry Drivers
  3. 2.3 Subcutaneous Allergy Immunotherapies Industry Opportunities and Challenges
  4. 2.4 Subcutaneous Allergy Immunotherapies Industry Restraints
3 Subcutaneous Allergy Immunotherapies Market by Manufacturers
  1. 3.1 Global Subcutaneous Allergy Immunotherapies Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Subcutaneous Allergy Immunotherapies Sales by Manufacturers (2021-2026)
  3. 3.3 Global Subcutaneous Allergy Immunotherapies Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Subcutaneous Allergy Immunotherapies Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Subcutaneous Allergy Immunotherapies Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Subcutaneous Allergy Immunotherapies Manufacturers, Product Type & Application
  7. 3.7 Global Subcutaneous Allergy Immunotherapies Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Subcutaneous Allergy Immunotherapies Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Subcutaneous Allergy Immunotherapies Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Subcutaneous Allergy Immunotherapies Tier 1, Tier 2, and Tier 3
4 Subcutaneous Allergy Immunotherapies Market by Type
  1. 4.1 Subcutaneous Allergy Immunotherapies Type Introduction
  2. 4.1.1 High Concentration
  3. 4.1.2 Low Concentration
  4. 4.2 Global Subcutaneous Allergy Immunotherapies Sales by Type
  5. 4.2.1 Global Subcutaneous Allergy Immunotherapies Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Subcutaneous Allergy Immunotherapies Sales by Type (2021-2032)
  7. 4.2.3 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2021-2032)
  8. 4.3 Global Subcutaneous Allergy Immunotherapies Revenue by Type
  9. 4.3.1 Global Subcutaneous Allergy Immunotherapies Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Subcutaneous Allergy Immunotherapies Revenue by Type (2021-2032)
  11. 4.3.3 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2021-2032)
5 Subcutaneous Allergy Immunotherapies Market by Application
  1. 5.1 Subcutaneous Allergy Immunotherapies Application Introduction
  2. 5.1.1 Primary Immunodeficiency
  3. 5.1.2 Secondary Immunodeficiency
  4. 5.1.3 Others
  5. 5.2 Global Subcutaneous Allergy Immunotherapies Sales by Application
  6. 5.2.1 Global Subcutaneous Allergy Immunotherapies Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Subcutaneous Allergy Immunotherapies Sales by Application (2021-2032)
  8. 5.2.3 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2021-2032)
  9. 5.3 Global Subcutaneous Allergy Immunotherapies Revenue by Application
  10. 5.3.1 Global Subcutaneous Allergy Immunotherapies Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Subcutaneous Allergy Immunotherapies Revenue by Application (2021-2032)
  12. 5.3.3 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2021-2032)
6 Global Subcutaneous Allergy Immunotherapies Sales by Region
  1. 6.1 Global Subcutaneous Allergy Immunotherapies Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Subcutaneous Allergy Immunotherapies Sales by Region (2021-2032)
  3. 6.2.1 Global Subcutaneous Allergy Immunotherapies Sales by Region (2021-2026)
  4. 6.2.2 Global Subcutaneous Allergy Immunotherapies Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Subcutaneous Allergy Immunotherapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Subcutaneous Allergy Immunotherapies Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Subcutaneous Allergy Immunotherapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Subcutaneous Allergy Immunotherapies Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Subcutaneous Allergy Immunotherapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Subcutaneous Allergy Immunotherapies Revenue by Region
  1. 7.1 Global Subcutaneous Allergy Immunotherapies Revenue by Region
  2. 7.1.1 Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Subcutaneous Allergy Immunotherapies Revenue by Region (2021-2026)
  4. 7.1.3 Global Subcutaneous Allergy Immunotherapies Revenue by Region (2027-2032)
  5. 7.1.4 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Subcutaneous Allergy Immunotherapies Revenue (2021-2032)
  8. 7.2.2 North America Subcutaneous Allergy Immunotherapies Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Subcutaneous Allergy Immunotherapies Revenue (2021-2032)
  11. 7.3.2 Europe Subcutaneous Allergy Immunotherapies Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Subcutaneous Allergy Immunotherapies Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Subcutaneous Allergy Immunotherapies Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Subcutaneous Allergy Immunotherapies Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 WOLW Pharma
  8. 8.2.1 WOLW Pharma Company Information
  9. 8.2.2 WOLW Pharma Business Overview
  10. 8.2.3 WOLW Pharma Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 WOLW Pharma Subcutaneous Allergy Immunotherapies Product Portfolio
  12. 8.2.5 WOLW Pharma Recent Developments
  13. 8.3 Stallergenes Greer
  14. 8.3.1 Stallergenes Greer Company Information
  15. 8.3.2 Stallergenes Greer Business Overview
  16. 8.3.3 Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Portfolio
  18. 8.3.5 Stallergenes Greer Recent Developments
  19. 8.4 Leti
  20. 8.4.1 Leti Company Information
  21. 8.4.2 Leti Business Overview
  22. 8.4.3 Leti Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Leti Subcutaneous Allergy Immunotherapies Product Portfolio
  24. 8.4.5 Leti Recent Developments
  25. 8.5 Holister Stier
  26. 8.5.1 Holister Stier Company Information
  27. 8.5.2 Holister Stier Business Overview
  28. 8.5.3 Holister Stier Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Holister Stier Subcutaneous Allergy Immunotherapies Product Portfolio
  30. 8.5.5 Holister Stier Recent Developments
  31. 8.6 HAL
  32. 8.6.1 HAL Company Information
  33. 8.6.2 HAL Business Overview
  34. 8.6.3 HAL Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HAL Subcutaneous Allergy Immunotherapies Product Portfolio
  36. 8.6.5 HAL Recent Developments
  37. 8.7 Allergy Therapeutics
  38. 8.7.1 Allergy Therapeutics Company Information
  39. 8.7.2 Allergy Therapeutics Business Overview
  40. 8.7.3 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Portfolio
  42. 8.7.5 Allergy Therapeutics Recent Developments
  43. 8.8 ALK-Abello
  44. 8.8.1 ALK-Abello Company Information
  45. 8.8.2 ALK-Abello Business Overview
  46. 8.8.3 ALK-Abello Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ALK-Abello Subcutaneous Allergy Immunotherapies Product Portfolio
  48. 8.8.5 ALK-Abello Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Subcutaneous Allergy Immunotherapies Value Chain Analysis
  2. 9.1.1 Subcutaneous Allergy Immunotherapies Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Subcutaneous Allergy Immunotherapies Production Mode & Process
  6. 9.2 Subcutaneous Allergy Immunotherapies Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Subcutaneous Allergy Immunotherapies Distributors
  9. 9.2.3 Subcutaneous Allergy Immunotherapies Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst